Klaviyo, Inc.

KVYO

CIK 0001835830 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$350M
↑+29.6% +$80Mvs FY2024 (Q4)
Operating Income
$171M
↑+39.7% +$48Mvs FY2024 (Q4)
Net Income
$170M
↑+41.9% +$50Mvs FY2024 (Q4)
Gross Profit
$253M
↑+27.4% +$54Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
50/100
  • Profitability
    0ROIC -4.8% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 4.27 (above 1.5 = solid)
  • Leverage
    0Insufficient data
  • Efficiency
    51Asset Turnover 0.86x (1.0+ = capital-efficient)
  • Growth
    100Revenue YoY +29.6% (10% = solid, 25%+ = elite)
  • Margin Trend
    49Op Margin -3.5% · trend -0.1pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project KVYO's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$12.33
Total enterprise IV
$3.59B
Diluted shares
0.29B
Terminal PV
$2.60B (72% of total)
Year-5 FCF
$306M
YearProjected FCFDiscounted PV
+1$225M$205M
+2$243M$201M
+3$263M$197M
+4$284M$194M
+5$306M$190M
Terminal$4.19B$2.60B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$9M
investment in PP&E
Stock-based comp (TTM)
$162M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$1.58B
everything owned
Total liabilities
$384M
everything owed
Stockholders' equity
$1.20B
shareholder claim

Recent performance · 15 quarters

Revenue↑+29.6% +$80M
$350M
Net Income↑+68.3% +$919K
$-426K
Free Cash Flow↑+57.1% +$33M
$91M
Operating Margin↑+2.2pts
-3.5%

Drill down